4lri
From Proteopedia
(Difference between revisions)
Line 5: | Line 5: | ||
</td></tr><tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4lri FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lri OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4lri RCSB], [http://www.ebi.ac.uk/pdbsum/4lri PDBsum]</span></td></tr> | </td></tr><tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4lri FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lri OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4lri RCSB], [http://www.ebi.ac.uk/pdbsum/4lri PDBsum]</span></td></tr> | ||
<table> | <table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Cytomegalovirus (CMV) is a widespread opportunistic pathogen that causes birth defects when transmitted transplacentally and severe systemic illness in immunocompromised individuals. MSL-109, a human monoclonal IgG isolated from a CMV seropositive individual, binds to the essential CMV entry glycoprotein H (gH) and prevents infection of cells. Here, we suggest a mechanism for neutralization activity by MSL-109. We define a genetic basis for resistance to MSL-109 and have generated a structural model of gH that reveals the epitope of this neutralizing antibody. Using surface-based, time-resolved FRET, we demonstrate that gH/gL interacts with glycoprotein B (gB). Additionally, we detect homodimers of soluble gH/gL heterodimers and confirm this novel oligomeric assembly on full-length gH/gL expressed on the cell surface. We show that MSL-109 perturbs the dimerization of gH/gL:gH/gL, suggesting that dimerization of gH/gL may be required for infectivity. gH/gL homodimerization may be conserved between alpha- and betaherpesviruses, because both CMV and HSV gH/gL demonstrate self-association in the FRET system. This study provides evidence for a novel mechanism of action for MSL-109 and reveals a previously undescribed aspect of viral entry that may be susceptible to therapeutic intervention. | ||
+ | |||
+ | Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109.,Fouts AE, Comps-Agrar L, Stengel KF, Ellerman D, Schoeffler AJ, Warming S, Eaton DL, Feierbach B Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8209-14. doi:, 10.1073/pnas.1404653111. Epub 2014 May 19. PMID:24843144<ref>PMID:24843144</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> |
Revision as of 06:28, 2 July 2014
Anti CMV Fab Fragment
|